Clinical Trials on Recurrent Liver Carcinoma in China
Total 6946 results
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedRecurrent Liver CarcinomaChina
-
The First Affiliated Hospital with Nanjing Medical...Not yet recruitingHepatocellular Carcinoma Recurrent | Post-orthotopic Liver TransplantationChina
-
Southwest Hospital, ChinaRecruitingHepatocellular Carcinoma RecurrentChina
-
Eastern Hepatobiliary Surgery HospitalCompletedRecurrent Hepatocellular CarcinomaChina
-
Ming ZhaoRecruitingRecurrent Hepatocellular CarcinomaChina
-
Sun Yat-sen UniversityRecruitingRecurrent Hepatocellular CarcinomaChina
-
Lion TCR Pte. Ltd.Third Affiliated Hospital, Sun Yat-Sen University; Agency for Science, Technology...UnknownRecurrent Hepatocellular CarcinomaChina
-
Xiaoshun HeLion TCR Pte. Ltd.UnknownRecurrent Hepatocellular CarcinomaChina
-
Sun Yat-sen UniversityRecruitingHepatocellular Carcinoma | Liver Cancer | Recurrent Tumor | Microwave Ablation | LenvatinibChina
-
Lion TCR Pte. Ltd.WithdrawnRecurrent Hepatocellular CarcinomaSingapore, China
-
Second Affiliated Hospital, School of Medicine,...UnknownRecurrent Hepatocellular Carcinoma | Stereotactic Body Radiotherapy | Microwave AblationChina
-
Shuhong YiRecruitingRecurrent Liver Cancer After Liver TransplantationChina
-
Southwest Hospital, ChinaUnknownHepatocellular Carcinoma RecurrentChina
-
RenJi HospitalRecruitingLiver Transplant; Complications | Hepatocellular Carcinoma RecurrentChina
-
RenJi HospitalRecruitingLiver Transplant; Complications | Hepatocellular Carcinoma RecurrentChina
-
Second Military Medical UniversityUnknownAdvanced Hepatocellular Carcinoma | Recurrence Hepatocellular CarcinomaChina
-
Shanghai Ninth People's Hospital Affiliated to...UnknownAdenocarcinoma | Recurrent Disease | Head and Neck Carcinoma | Distantly Metastatic Malignant NeoplasmChina
-
Shanghai Jiao Tong University School of MedicineShanghai Changzheng HospitalUnknownLiver Transplantation | Hepatocellular Carcinoma | Adjuvant Chemotherapy | Survival | Tumor Recurrence and MetastasisChina
-
Lei LiCompletedChemotherapy | Recurrent Cervical Carcinoma | Immunotherapy | Anti-PD-1 Antibody | Persistent Advanced Cervical CarcinomaChina
-
Lei LiRecruitingChemotherapy | Recurrent Cervical Carcinoma | Survival Outcomes | Targeted Therapy | Adverse Effect | Metastatic Cervical Carcinoma | Persistent Advanced Cervical CarcinomaChina
-
Lei LiRecruitingRecurrent Cervical Carcinoma | Radiotherapy | Objective Response Rate | Overall Survival | Progression-free Survival | Epidermal Growth Factor Receptor | NimotuzumabChina
-
Liangjun Zhu M.M.Zhangjiagang First People's HospitalRecruitingMetastatic or Recurrent Gastric AdenocarcinomaChina
-
Fudan UniversityRecruitingRecurrence | Hepatocellular CarcinomaChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingPatients With Resectable Hepatocellular Carcinoma Who Are at High Risk of Recurrence or MetastasiChina
-
Lei LiRecruitingChemotherapy | Recurrent Cervical Carcinoma | Immune Checkpoint Inhibitors | Anti-PD-1 Antibody | Persistent Advanced Cervical Carcinoma | Albumin-bound PaclitaxelChina
-
Lei LiCompletedChemotherapy | Recurrent Cervical Carcinoma | Apatinib | Targeted Therapy | Persistent Advanced Cervical Carcinoma | Vascular Endothelial Growth Factor 2 InhibitorChina
-
Shanghai Miracogen Inc.RecruitingRecurrent or Metastatic Squamous Cell Carcinoma of Head and NeckChina
-
Peking Union Medical College HospitalSun Yat-Sen Memorial Hospital of Sun Yat-Sen University; The Second Affiliated...RecruitingRecurrent Ovarian CarcinomaChina
-
Shanghai Ninth People's Hospital Affiliated to...RecruitingPatients With Locally Recurrent Resectable Head and Neck Squamous Cell CarcinomaChina
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingAdjuvant Therapy in Patients With Hepatocellular Carcinoma (HCC) at High Risk of Recurrence After Curative Resection or AblationChina
-
Chinese PLA General HospitalImmunotech Applied Science Ltd.RecruitingHepatocellular Carcinoma (HCC)China
-
Lei LiRecruitingRecurrent Cervical Carcinoma | Radiotherapy | Immunotherapy | Survival Outcomes | Immune Checkpoint Inhibitors | Objective Response Rate | Metastatic Cervical Carcinoma | Tislelizumab | Persistent Cervical Carcinoma | Anti-programmed Cell Death Receptor 1China
-
AkesoNot yet recruitingHepatocellular CarcinomaChina
-
Newish Technology (Beijing) Co., Ltd.Cancer Institute and Hospital, Chinese Academy of Medical SciencesRecruitingHepatocellular CarcinomaChina
-
Sun Yat-sen UniversityRecruiting
-
Fudan UniversityActive, not recruitingHepatocellular CarcinomaChina
-
Fudan UniversityTerminatedHepatocellular CarcinomaChina
-
Eastern Hepatobiliary Surgery HospitalUnknownHepatocellular CarcinomaChina
-
Shuqun ChengUnknownHepatocellular CarcinomaChina
-
Beijing HospitalRecruitingHepatocellular CarcinomaChina
-
Beijing Ditan HospitalXiyuan Hospital of China Academy of Chinese Medical SciencesCompletedHepatocellular CarcinomaChina
-
Shanghai Zhongshan HospitalUnknownHepatocellular CarcinomaChina
-
Eastern Hepatobiliary Surgery HospitalCompletedHepatocellular CarcinomaChina
-
Tianjin Medical University Cancer Institute and...Not yet recruitingHepatocellular CarcinomaChina
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingHepatocellular CarcinomaChina
-
Yunhua TanSouthwest Hospital, ChinaUnknownHepatocellular CarcinomaChina
-
Eastern Hepatobiliary Surgery HospitalUnknownRecurrence | Hepatocellular CarcinomaChina
-
Eastern Hepatobiliary Surgery HospitalUnknownHepatocellular CarcinomaChina
-
Eastern Hepatobiliary Surgery HospitalUnknownHepatocellular CarcinomaChina
-
Third Affiliated Hospital, Sun Yat-Sen UniversityUnknownHepatocellular CarcinomaChina